🔗 Share this article

Grammy-winning R&B singer D’Angelo died on October 14 at age 51 after a personal fight with pancreatic malignancy.

“The shining star of our family has faded away for us in this life,” his family stated. “After a prolonged and brave battle with the disease, we are deeply saddened to announce that Michael D’Angelo Archer, known to his fans around the world as D’Angelo, has been taken from us.”

D’Angelo made a lasting impact on the music industry with his pioneering modern soul style and partnerships with renowned musicians.

He released his first record, “Brown Sugar,” in the mid-nineties to instant praise. The record reached the fourth spot on the R&B charts, went platinum soon after, and received multiple award nominations.

However, it was his sophomore release, “Voodoo,” in the year 2000 that boosted his music career into the stratosphere. The record debuted at the top spot on both Billboard’s Top R&B Albums chart and the Billboard 200. He won two Grammy Awards: Top R&B Record and Outstanding Male Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” cemented D’Angelo’s standing as a icon, albeit a reluctant one, in the cultural zeitgeist. The personal depiction featured the artist, famously stripped down to his midsection, performing straight into the lens.

D’Angelo retreated from the spotlight after releasing Voodoo and openly battled with drugs and alcohol. In 2005, he was part of a severe vehicle accident that put him in critical condition.

Over ten years later, his last record, “Black Messiah” (2014), confirmed his lasting popularity with another top chart entry on the R&B chart and a award for Best R&B Album.

Again, in his own mysterious fashion, D’Angelo had limited public appearances in the subsequent period.

The musician was scheduled as a top act for the 2025 music event, but his appearance was called off, citing an “unexpected health issue.”

Although details are sparse about D’Angelo’s well-being in the weeks before his death, he had apparently been hospitalized for months and in palliative care for a fortnight.

D’Angelo’s demise is a clear example of the harmful impact of pancreatic cancer, one of the deadliest and least preventable types of the disease, on a gifted artist whose existence was ended too soon.

“We are grieved that he can only provide cherished moments with his loved ones, but we are eternally grateful for the legacy of extraordinarily moving music he has left us,” his kin said.

Pancreatic Malignancy: Deadly and Rarely Preventable

Pancreatic cancer affects the digestive organ, a small organ that generates insulin and plays an essential role in digestion, among additional roles. The position and dimensions of the organ in the body make it more difficult to identify malignancy.

Although this cancer makes up only about 3% of cancer diagnoses each year in the U.S., it is causes 7% of cancer deaths.

Nearly seventy thousand individuals will be diagnosed with this condition and about fifty-two thousand will succumb to the illness in 2025.

“This malignancy is one of the deadliest cancers, with an aggressive tumor and poor prognosis. We have limited and poor therapies, and a smaller window to make a significant difference on the well-being of patients,” noted a cancer specialist.

Since this disease rarely causes initial signs, it’s often identified only after the disease is advanced. Although a individual has symptoms they are usually nonspecific and may be mistaken for a number of everyday ailments.

“As of yet, there is no good way to detect this malignancy in the early stages, apart from listening to your body and consulting your physician if there are new or unusual signs,” said a health expert.

Common symptoms of pancreatic cancer encompass:

• discomfort in the stomach or back
• weight loss
• jaundice
• loss of appetite
• brownish urine
• pale or fatty bowel movements
• loose stools
• increased appetite or thirst
• feeling sick

At 51 years old, D’Angelo’s death is an exception, as pancreatic cancer is typically found in individuals in the 65 to 75 range. However, many cancers, such as this type, have become more common in younger people.

“Pancreatic cancer diagnosed before the age of 50 is deemed uncommon, yet alarmingly, doctors are noticing a growing number of younger individuals suffering from this condition,” said a expert.

Genetic Background Affects Cancer Risk

Without effective detection methods for this malignancy, professionals stressed the significance of understanding your family’s cancer history. Some risk factors, such as smoking and obesity also have an influence in the development of pancreatic cancer.

Black individuals have the highest incidence of pancreatic cancer in the United States and are more prone to be found to have untreatable disease.

“The initial action toward reducing one’s risk of pancreatic cancer is assessing individual susceptibility. Individuals should examine their genetic background, genetic background, and health issues, such as diabetes, chronic pancreatitis, or overweight that may increase their vulnerability,” advised a medical professional.

Inherited genetic risk factors are linked to as much as 10% of all this malignancy instances. If someone in your family has had pancreatic cancer, you may want to consider genetic testing.

“For people with a family history of this condition or those having elevated risk genetic mutations, checking may involve sophisticated scans such as MRI scans or internal ultrasound to detect early changes in the pancreas,” he explained.

For those looking to lower their chance, lifestyle changes may have an effect. The most effective step you can take to lower your risk of this disease is to quit smoking, and if you are a non-smoker, stay away altogether.

Excessive alcohol consumption is associated with pancreatitis, a risk factor for pancreatic cancer, so limiting or avoiding drinks may help lower your chance.

Managing your body mass or shedding pounds may also help reduce your risk. Individuals with obesity are 20% more likely to develop this disease. This malignancy also is more frequent in those with blood sugar issues, and reducing weight can also reduce the risk of type 2 diabetes.

In spite of pancreatic cancer’s grim outlook, there is reason for optimism.

“We are making progress with treatments and newer combination chemotherapy. There are emerging precision medicines that are already making an impact,” said a specialist.

For numerous individuals, however, awareness about this uncommon but {dev